ACOG (Alpha Cognition) Cash per Share: $2.49 (As of Mar. 2026)


ACOG Alpha Cognition Inc ACOG
31 GF Score
Price $8.41
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition Cash per Share?

Alpha Cognition ACOG -1.18% 31 Cash per Share is $2.49 as of Mar. 2026. GuruFocus rates ACOG with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Alpha Cognition's Cash per Share for the quarter that ended in Mar. 2026 was $2.49.


Alpha Cognition  (NAS:ACOG) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Alpha Cognition Cash per Share Related Terms


Alpha Cognition Cash per Share Historical Data

* Premium members only.

The historical data trend for Alpha Cognition's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Cognition Cash per Share Chart

Alpha Cognition Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial 4.18 0.77 0.30 3.03 3.04

Alpha Cognition Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.84 2.46 2.18 3.04 2.49
ACOG
31GF Score
Alpha Cognition Inc ACOG
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Cognition Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Alpha Cognition's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Alpha Cognition's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of $2.49 mean?
Alpha Cognition (ACOG) has a Cash per Share of $2.49 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Alpha Cognition and its competitors.
Is Alpha Cognition's Cash per Share too high?
Alpha Cognition's current Cash per Share is $2.49. Overall, Alpha Cognition has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's Cash per Share compare to HURA and MENS?
Alpha Cognition's Cash per Share of $2.49 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Biotechnology company?
A good Cash per Share depends on the Biotechnology industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Alpha Cognition and its competitors. Alpha Cognition's current Cash per Share is $2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current Cash per Share of $2.49. The current Cash per Share is $2.49. Alpha Cognition's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current Cash per Share is $2.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Cognition Business Description

Other Exchanges 7N70:Germany
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
31GF Score

Get the complete analysis for ACOG

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.41
Price